TCM
CANO

Thames Capital Management’s Cano Health, Inc. CANO Stock Holding History

Thames Capital Management’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-618
Closed -$828K – 65
2020
Q4 		$828K Buy
+618
New +$707K 0.23% 52

Other funds holding CANO

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Thames Capital Management's CANO Position: Q1 2021 in Review

Thames Capital Management sold out of Cano Health, Inc. (CANO) in Q1 2021, closing a stake of 618 shares — an estimated $828K sold.

Thames Capital Management first reported a position in CANO in Q4 2020 and held it in 1 quarter. The position peaked at $828K in Q4 2020. 71 funds tracked by Wall St. Rank hold CANO as of Q1 2021.

  • Thames Capital Management reported no remaining Cano Health, Inc. position as of Q1 2021 after selling out during the quarter.
  • Thames Capital Management sold 618 Cano Health, Inc. shares in Q1 2021, an estimated $828K.
  • Thames Capital Management first reported a position in Cano Health, Inc. in Q4 2020 and held it in 1 quarter.
  • Thames Capital Management's Cano Health, Inc. position peaked at $828K in Q4 2020.
  • 71 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2021.

Based on Thames Capital Management's 13F filing for Q1 2021, filed 13 May 2021.